Aurora Cannabis ACB
NASDAQ ACB
$3.81 -0.11 (-2.69%)
As of: Aug 20, 2026 · 3:59 PM EDT

Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Income from Non-Controlling Interests of $7.3 million for Q1 2026, up 435.49% year-over-year from $1.4 million in Q1 2025, and up 371.88% quarter-over-quarter from -$2.7 million in Q4 2025.

Aurora Cannabis (ACB) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Income from Non-Controlling Interests for 8 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests rose 435.49% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $84057.7 (up 115.06% YoY), while the FY2025 annual figure was -$487005.4, up 82.47% from the prior year.
  • Income from Non-Controlling Interests climbed to $7.3 million in Q1 2026 per ACB's latest filing, from -$2.7 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $7.3 million in Q1 2026 and bottomed at -$3.4 million in Q2 2025.
  • Historically, Income from Non-Controlling Interests has averaged -$260404.2 across 5 years, with a median of -$677341.4 in 2024.
  • Annual changes were most pronounced in 2025 — Income from Non-Controlling Interests slumped 1044.0% — and 2026, when it jumped 435.49%.
  • Aurora Cannabis' Income from Non-Controlling Interests stood at -$1.5 million in 2022, then jumped by 48.58% to -$781545.8 in 2023, then surged by 70.14% to -$233366.8 in 2024, then plunged by 1044.0% to -$2.7 million in 2025, then surged by 371.88% to $7.3 million in 2026.
  • Business Quant data shows ACB's Income from Non-Controlling Interests at $7.3 million in Q1 2026, -$2.7 million in Q4 2025, and -$1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Aurora Cannabis 235.30 Mn 162.99 Mn 25.75 Mn 500,987.21

Historic Data

Download Data
DateValue
Mar 31, 2026 7.26 Mn
Dec 31, 2025 -2.67 Mn
Sep 30, 2025 -1.14 Mn
Jun 30, 2025 -3.36 Mn
Mar 31, 2025 1.36 Mn
Dec 31, 2024 -233,366.82
Sep 30, 2024 -677,341.35
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 264,934.42
Dec 31, 2023 -781,545.80
Sep 30, 2023 -1.20 Mn
Dec 31, 2022 -1.52 Mn
Sep 30, 2022 -216,989.19
Jun 30, 2022 8,627.75
Mar 31, 2022 9,473.70
Dec 31, 2021 -291,154.34
Sep 30, 2020 -1.10 Mn
Sep 30, 2018 -979,927.44